抗炎性 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "抗炎性" in Chinese language version.

refsWebsite

Global rank Chinese rank

15doi.org

2^nd place

23^rd place

14nih.gov

4^th place

5^th place

1termonline.cn

9,524^th place

325^th place

1naer.edu.tw

4,367^th place

148^th place

1books.google.com

3^rd place

8^th place

1usdbiology.com

low place

1web.archive.org

1^st place

1handle.net

102^nd place

492^nd place

1researchgate.net

120^th place

337^th place

books.google.com (Global: 3^rd place; Chinese: 8^th place)

王博. 药物学基础. 重庆大学电子音像出版社. 2021: 142. ISBN 9787568928205.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Ingawale DK, Mandlik SK. New insights into the novel anti-inflammatory mode of action of glucocorticoids. Immunopharmacol Immunotoxicol. April 2020, 42 (2): 59–73. PMID 32070175. doi:10.1080/08923973.2020.1728765.
Escoter-Torres L, Caratti G, Mechtidou A, Tuckermann J, Uhlenhaut NH, Vettorazzi S. Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor. Front Immunol. 2019, 10: 1859. PMC 6693390 . PMID 31440248. doi:10.3389/fimmu.2019.01859 .
Nichols DE, Johnson MW, Nichols CD. Psychedelics as Medicines: An Emerging New Paradigm. Clin Pharmacol Ther. February 2017, 101 (2): 209–219. PMID 28019026. doi:10.1002/cpt.557.
Flanagan TW, Nichols CD. Psychedelics and Anti-inflammatory Activity in Animal Models. Disruptive Psychopharmacology. Current Topics in Behavioral Neurosciences 56. 2022: 229–245. ISBN 978-3-031-12183-8. PMID 35546383. doi:10.1007/7854_2022_367.
Nichols CD. Psychedelics as potent anti-inflammatory therapeutics. Neuropharmacology. November 2022, 219: 109232. PMID 36007854. doi:10.1016/j.neuropharm.2022.109232 .
Flanagan TW, Nichols CD. Psychedelics as anti-inflammatory agents (PDF). Int Rev Psychiatry. August 2018, 30 (4): 363–375 [2025-03-13]. PMID 30102081. doi:10.1080/09540261.2018.1481827. （原始内容存档 (PDF)于2024-08-26）.
Thompson C, Szabo A. Psychedelics as a novel approach to treating autoimmune conditions. Immunol Lett. December 2020, 228: 45–54. PMID 33035575. doi:10.1016/j.imlet.2020.10.001. hdl:10852/80687 .
Low ZX, Ng WS, Lim ES, Goh BH, Kumari Y. The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry. September 2024, 136: 111139. PMID 39251080. doi:10.1016/j.pnpbp.2024.111139 .
Flanagan TW, Billac GB, Landry AN, Sebastian MN, Cormier SA, Nichols CD. Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore. ACS Pharmacol Transl Sci. April 2021, 4 (2): 488–502. PMC 8033619 . PMID 33860179. doi:10.1021/acsptsci.0c00063.
Luethi, Dino; Liechti, Matthias E. Drugs of Abuse Affecting 5-HT2B Receptors. 5-HT2B Receptors 35. Cham: Springer International Publishing. 2021: 277–289. ISBN 978-3-030-55919-9. doi:10.1007/978-3-030-55920-5_16.
Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R. The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. J Psychopharmacol. September 2023, 37 (9): 876–890. PMID 37572027. doi:10.1177/02698811231190865.
Rouaud A, Calder AE, Hasler G. Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. J Psychopharmacol. March 2024, 38 (3): 217–224. PMC 10944580 . PMID 38214279. doi:10.1177/02698811231225609.
Nahlawi A, Ptaszek LM, Ruskin JN. Cardiovascular effects and safety of classic psychedelics. Nat Cardiovasc Res. February 2025, 4 (2): 131–144. PMID 39910289. doi:10.1038/s44161-025-00608-2.
Wsół A. Cardiovascular safety of psychedelic medicine: current status and future directions. Pharmacol Rep. December 2023, 75 (6): 1362–1380. PMC 10661823 . PMID 37874530. doi:10.1007/s43440-023-00539-4.
McIntyre RS. Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents. Expert Opin Drug Saf. 2023, 22 (10): 881–883. PMID 37581427. doi:10.1080/14740338.2023.2248883.

handle.net (Global: 102^nd place; Chinese: 492^nd place)

hdl.handle.net

Thompson C, Szabo A. Psychedelics as a novel approach to treating autoimmune conditions. Immunol Lett. December 2020, 228: 45–54. PMID 33035575. doi:10.1016/j.imlet.2020.10.001. hdl:10852/80687 .

naer.edu.tw (Global: 4,367^th place; Chinese: 148^th place)

terms.naer.edu.tw

消炎藥. 樂詞網. 國家教育研究院（中文（臺灣））.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Ingawale DK, Mandlik SK. New insights into the novel anti-inflammatory mode of action of glucocorticoids. Immunopharmacol Immunotoxicol. April 2020, 42 (2): 59–73. PMID 32070175. doi:10.1080/08923973.2020.1728765.
Escoter-Torres L, Caratti G, Mechtidou A, Tuckermann J, Uhlenhaut NH, Vettorazzi S. Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor. Front Immunol. 2019, 10: 1859. PMC 6693390 . PMID 31440248. doi:10.3389/fimmu.2019.01859 .
Nichols DE, Johnson MW, Nichols CD. Psychedelics as Medicines: An Emerging New Paradigm. Clin Pharmacol Ther. February 2017, 101 (2): 209–219. PMID 28019026. doi:10.1002/cpt.557.
Flanagan TW, Nichols CD. Psychedelics and Anti-inflammatory Activity in Animal Models. Disruptive Psychopharmacology. Current Topics in Behavioral Neurosciences 56. 2022: 229–245. ISBN 978-3-031-12183-8. PMID 35546383. doi:10.1007/7854_2022_367.
Nichols CD. Psychedelics as potent anti-inflammatory therapeutics. Neuropharmacology. November 2022, 219: 109232. PMID 36007854. doi:10.1016/j.neuropharm.2022.109232 .
Flanagan TW, Nichols CD. Psychedelics as anti-inflammatory agents (PDF). Int Rev Psychiatry. August 2018, 30 (4): 363–375 [2025-03-13]. PMID 30102081. doi:10.1080/09540261.2018.1481827. （原始内容存档 (PDF)于2024-08-26）.
Thompson C, Szabo A. Psychedelics as a novel approach to treating autoimmune conditions. Immunol Lett. December 2020, 228: 45–54. PMID 33035575. doi:10.1016/j.imlet.2020.10.001. hdl:10852/80687 .
Low ZX, Ng WS, Lim ES, Goh BH, Kumari Y. The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry. September 2024, 136: 111139. PMID 39251080. doi:10.1016/j.pnpbp.2024.111139 .
Flanagan TW, Billac GB, Landry AN, Sebastian MN, Cormier SA, Nichols CD. Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore. ACS Pharmacol Transl Sci. April 2021, 4 (2): 488–502. PMC 8033619 . PMID 33860179. doi:10.1021/acsptsci.0c00063.
Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R. The risk of chronic psychedelic and MDMA microdosing for valvular heart disease. J Psychopharmacol. September 2023, 37 (9): 876–890. PMID 37572027. doi:10.1177/02698811231190865.
Rouaud A, Calder AE, Hasler G. Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. J Psychopharmacol. March 2024, 38 (3): 217–224. PMC 10944580 . PMID 38214279. doi:10.1177/02698811231225609.
Nahlawi A, Ptaszek LM, Ruskin JN. Cardiovascular effects and safety of classic psychedelics. Nat Cardiovasc Res. February 2025, 4 (2): 131–144. PMID 39910289. doi:10.1038/s44161-025-00608-2.
Wsół A. Cardiovascular safety of psychedelic medicine: current status and future directions. Pharmacol Rep. December 2023, 75 (6): 1362–1380. PMC 10661823 . PMID 37874530. doi:10.1007/s43440-023-00539-4.
McIntyre RS. Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents. Expert Opin Drug Saf. 2023, 22 (10): 881–883. PMID 37581427. doi:10.1080/14740338.2023.2248883.

researchgate.net (Global: 120^th place; Chinese: 337^th place)

Flanagan TW, Billac GB, Landry AN, Sebastian MN, Cormier SA, Nichols CD. Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore. ACS Pharmacol Transl Sci. April 2021, 4 (2): 488–502. PMC 8033619 . PMID 33860179. doi:10.1021/acsptsci.0c00063.

termonline.cn (Global: 9,524^th place; Chinese: 325^th place)

抗炎药. 术语在线. 全国科学技术名词审定委员会. （简体中文）

usdbiology.com (Global: low place; Chinese: low place)

Flanagan TW, Nichols CD. Psychedelics as anti-inflammatory agents (PDF). Int Rev Psychiatry. August 2018, 30 (4): 363–375 [2025-03-13]. PMID 30102081. doi:10.1080/09540261.2018.1481827. （原始内容存档 (PDF)于2024-08-26）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Flanagan TW, Nichols CD. Psychedelics as anti-inflammatory agents (PDF). Int Rev Psychiatry. August 2018, 30 (4): 363–375 [2025-03-13]. PMID 30102081. doi:10.1080/09540261.2018.1481827. （原始内容存档 (PDF)于2024-08-26）.

抗炎性 (Chinese Wikipedia)

books.google.com (Global: 3rd place; Chinese: 8th place)

doi.org (Global: 2nd place; Chinese: 23rd place)

handle.net (Global: 102nd place; Chinese: 492nd place)